(Press-News.org) PLYMOUTH MEETING, PA [September 10, 2025] — New research published in the September 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network validates the use of a specifically-curated tool for determining which medications may be causing harm for older patients with cancer. Researchers affiliated with the Veterans Affairs (VA) Healthcare System in Boston evaluated a tool based on information from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Older Adult Oncology, called the “Geriatric Oncology Potentially Inappropriate Medications” scale, or “GO-PIMS” for short. They used data from the VA Cancer Registry to determine how well the GO-PIMs scale can identify high-risk medications and their association with outcomes in more than 380,000 older adults diagnosed with cancer, both solid tumors and hematologic malignancies, between January 1, 2000, and December 31, 2022.
According to their results, 38% of patients were prescribed at least one GO-PIMs, most-commonly selective serotonin reuptake inhibitors (SSRIs). Each additional GO-PIM was associated with a 66% increase in odds of being mildly or moderately-to-severely frail at diagnosis. These findings confirm the GO-PIMS tool can identify high-risk medications that impact patients and outcomes negatively.
“This research is about making treatment safer and more tolerable—especially for older adults who are already vulnerable to adverse events,” explained lead author Jennifer La, PhD, of Harvard Medical School and the VA Boston Cooperative Studies Program Center. “We found that many patients are prescribed chronic and supportive care medications that may do more harm than good—especially when they’re already dealing with complex health issues. These medications, rapidly identified by the GO-PIMs scale, were linked to higher rates of frailty, hospitalizations, and even death. By identifying and reviewing these prescriptions early, we can potentially improve safety and outcomes for people undergoing cancer treatment.”
“We hope this research encourages oncology teams to routinely review medication lists—not just count the number of drugs but look closely at which ones might be risky,” added senior author Clark DuMontier, MD, MPH, also of Harvard Medical School and VA Boston/Brigham and Women’s Hospital/Dana-Farber Cancer Institute. “Tools like the GO-PIMs scale can be built into electronic health records to flag concerning prescriptions. We need to weigh the risks and benefits carefully, and when possible, consider safer alternatives or deprescribing. Finding the right balance requires individual considerations for each patient, and we hope tools like GO-PIMs and frailty assessment will help make that possible. We are currently piloting such an approach using GO-PIMs in our local clinic.”
“A cancer diagnosis is an ideal time to revisit medication safety, as older adults often begin systemic therapy with complex regimens, shifting goals of care, and frequent clinical contact,” commented Mostafa Mohamed, MBBCh, PhD, University of Rochester Medical Center, who was not involved in this research. “La et al. highlighted the increased prevalence and clinical relevance of potentially inappropriate prescribing in older adults with cancer using the GO-PIMs scale in a national dataset. This analysis is unique in its use of a cancer-specific PIMs framework (GO-PIMs) derived from NCCN Guidelines in a real-world, national setting.
Dr. Mohamed continued: “This research underscores the opportunity to improve care by addressing medication-related risks. The next step is integrating tools like GO-PIMs into everyday practice, not only to flag high-risk medications, but also to support actionable changes in treatment planning and patient care.”
Dr. Mohamed is the author of a longer response to the study that has also published in the September issue of JNCCN. To read the entire study “Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System” and the corresponding “The Last Word” commentary, visit JNCCN.org.
The GO-PIMs scale was previously validated for demonstrating frailty in older patients with hematologic malignancies treated at a single institution. Learn more about those findings, from August 2022, here: https://www.nccn.org/home/news/NewsDetails?NewsId=3404.
JNCCN’s Impact
Cancer studies, like the ones above, are continuing to have a growing impact on patient care. The Impact Factor for JNCCN has now risen to 16.4, a significant increase over the previous rating of 14.8. The index is based on the number of articles that cite research from JNCCN over the past two years. It is calculated by Clarivate, an independent data, insights, and analysis organization. JNCCN now ranks in the top 94.9 percentile of peer-reviewed, cancer research journals.
# # #
About JNCCN—Journal of the National Comprehensive Cancer Network
More than 25,000 oncologists and other cancer care professionals across the United States read JNCCN—Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about innovation in translational medicine, and scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), review articles elaborating on guidelines recommendations, health services research, and case reports highlighting molecular insights in patient care. JNCCN is published by Harborside/BroadcastMed. Visit JNCCN.org. To inquire if you are eligible for a FREE subscription to JNCCN, visit NCCN.org/jnccn/subscribe. Follow JNCCN at x.com/JNCCN.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
Washington, September 10, 2025—State school finance reforms designed to close funding gaps between high- and low-income districts did not reduce racial and ethnic funding inequities and in some cases increased them, according to new research. As school desegregation efforts slowed in the decades following the 1980s, these findings highlight the limitations of income-based approaches in addressing racial funding disparities in education.
The study, by Emily Rauscher of Brown University and Jeremy E. Fiel of Rice ...
WASHINGTON—The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field.
Endocrinologists are scientists and medical doctors who specialize in unraveling the mysteries of hormone disorders to care for patients and treat diseases. These professionals have achieved breakthroughs in scientific discoveries and clinical care benefiting people with hundreds of conditions, including diabetes, thyroid disorders, obesity, hormone-related cancers, growth problems, osteoporosis and infertility.
Established in 1944, the Society’s ...
Endometrial cancer is a major gynecologic malignancy, with HGEC comprising aggressive variants such as Grade 3 endometrioid, serous, clear cell, undifferentiated/dedifferentiated carcinomas, carcinosarcoma, and mesonephric-like adenocarcinoma. These tumors are characterized by poor prognosis and resistance to conventional therapies. The limitations of traditional histopathological diagnosis underscore the need for molecular refinement to guide clinical management.
Histopathological Subtypes of HGEC
FIGO Grade 3 Endometrioid Carcinoma (HG-EEC): Characterized ...
AMHERST, Mass. — Physicists have long believed that black holes explode at the end of their lives, and that such explosions happen—at most—only once every 100,000 years. But new research published in Physical Review Letters by physicists at the University of Massachusetts Amherst has found a more than 90% probability that one of these black-hole explosions might be seen within the decade, and that, if we are prepared, our current fleet of space and earthbound telescopes could witness the event.
Such an explosion would be strong evidence of a theorized but never observed kind of black hole, called a “primordial black hole,” ...
The university stage, particularly its beginning, is a time of tension and emotional stress for young students—many of whom are under the age of 20. This is a group in which suicidal ideation has increased significantly in recent years, surpassing the general population. Now, a study led by the Hospital del Mar Research Institute has quantified the prevalence of suicidal thoughts among university students and identified the main associated risk factors. The study, part of the World Mental Health International College Student Initiative (WMH-ICS) led by Harvard University in the United States, ...
University of Virginia School of Medicine researchers have received a $2.3 million grant from the U.S. Department of Defense to test whether a cutting-edge magnetic resonance imaging (MRI) scanner can identify now-undetectable brain injuries in soldiers exposed to blasts.
Previous research studies have shown blast exposures may create distinct brain scarring caused by nervous system cells called astrocytes, said James R. Stone, MD, PhD, the UVA Health radiologist leading the research team. However, this scarring can only be seen after a patient’s ...
For patients who have mobility impairments or other conditions that require inpatient rehabilitation, Mount Sinai Health System has opened a new, modern, high-tech facility at Mount Sinai Morningside on the West Side of Manhattan at 1111 Amsterdam Avenue (at 114th Street).
All inpatient services formerly housed at The Mount Sinai Hospital on the East Side have relocated to this newly renovated space with enhanced equipment and technology, still called the Mount Sinai Rehabilitation Center. It aims to enhance care to patients with a wide range of rehabilitative needs, including brain and spinal cord injuries, stroke, ...
Washington, D.C.: Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced the opening of a fourth round of funding opportunities for the Discovery Research program. BD² invites scientists across all disciplines to apply for up to $4.5 million per grant. Successful teams will undertake groundbreaking research into the genetic, molecular, cellular, circuit, and behavioral mechanisms of bipolar disorder, especially applications that address the following:
Cellular and molecular mechanisms of mood-state switching;
Biological ...
Household waste constitutes 30–40% of municipal solid waste globally. Separating waste at the household level into compostable, recyclable, and non-recyclable is a crucial first step for local governments to process solid waste effectively. However, large gaps between a person’s willingness to separate waste and actually separating waste have been seen across the world. Understanding the factors that affect people’s intention and behavior of separating household waste can help create more effective policies regarding household-level waste separation.
However, ...
Flexible pressure sensors can detect subtle mechanical stimuli, making them suitable for use in wearable sensors for human health monitoring and motion analysis. However, current sensors suffer from insufficient sensitivity, poor durability, and subpar stability. In a new study, taking inspiration from cat whiskers, researchers developed novel biomass fiber/sodium alginate aerogel (BFA)-based sensors that demonstrated excellent pressure sensitivity, durability, and rapid response, while being suitable for human physiological monitoring and motion analysis.
The rapid development of wearable electronic sensors for use in health monitoring, ...
